Broward Health settles with ex-CEO for $975,000

Broward Health
Broward Health ended a longtime feud with its former CEO. (Broward Health)

Broward Health’s Board of Directors has approved a $975,000 settlement with former CEO Pauline Grant.

The settlement ends a long legal battle that began back in 2016 when Grant sued the South Florida public hospital system for her firing over anti-kickback violations. The settlement resolves legal matters between the two parties and includes an agreement by Grant to help the hospital system in an upcoming federal investigation, the Sun Sentinel reports.

The longtime Broward Health executive had asked for severance equivalent to a year’s salary, about $619,000, claiming that the system violated state public meetings law by discussing her firing prior to opening a board meeting. Later on, the system ended up countersuing, denying Grant severance due to her violation of conduct.

Innovation Awards

Submit your nominations for the FierceHealthcare Innovation Awards

The FierceHealthcare Innovation Awards showcases outstanding innovation that is driving improvements and transforming the industry. Our expert panel of judges will determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry. Deadline for submissions is this Friday, October 18th.

RELATED: Hospital crisis: Broward Health battles a ‘cultural civil war’

The conduct allegedly involved illegally distributing contracts to orthopedic surgeons when Grant sat on the board of directors of a facility that contracts with the Florida hospital system. The allegations were never proven.

Broward Health operates four hospitals and urgent care and outpatient centers in South Florida.

Suggested Articles

As drugmakers face billions in legal settlements and judgments, we must keep our eye on what will truly defeat the opioid crisis.

As the public debate on health reform rolls on, a new report analyzes how these different approaches could impact insurers' bottom lines.

A House panel is going to consider several changes to Nancy Pelosi's drug prices plan, including stiff penalties for not being transparent.